Qonstio supports chronic patients with diabetes and hypertension through Naira, a voice agent that calls, listens, and motivates. No app. No smartphone. Just a phone call.
Reminder apps systematically fail with the most costly patient profile: people over 60 with a history of digital drop-off.
The patient doesn't remember to take their medication at the right time. Push notifications don't reach them, go unseen, or are simply ignored.
HbA1c isn't felt. Blood pressure doesn't hurt. The benefits are invisible in the short term while the effort is daily and immediate.
The doctor sees the patient every 3–6 months. In that interval, no one detects the early signs of abandonment or resolves the patient's specific doubts.
Naira calls the patient at the agreed time. No downloads, no passwords, no touchscreen needed. They just have to pick up the phone.
Works with any mobile or landline. Designed for older patients with low digital literacy.
Naira remembers what the patient said the week before and builds an ongoing follow-up relationship — not a generic call.
Every interaction generates structured data for the pharmacist or program manager: adherence levels, patient status, and alert signals.
Qonstio integrates into a single voice interface the three interventions that evidence shows are necessary to sustain long-term adherence.
Naira calls the patient at the agreed time. It detects patterns of missed doses and automatically escalates if several days go by without adherence — no action required from the patient.
Operational adherenceVisible progress through streaks and personalised narrative. Reflective questions based on the ReflectEasy methodology help the patient maintain the habit when the benefit is invisible.
Sustained adherencePeriodic conversations to track symptoms and overall condition. Early detection of decompensation signals. Structured reports for the healthcare professional or pharmacist.
Clinical evidenceQonstio operates on a B2B model. The patient is the end user; the client is the institutional actor with a measurable economic problem.
Non-adherence reduces perceived efficacy. Qonstio enables patient support from the pharmacy side without adding burden to the medical team.
Every percentage point gained in adherence directly translates into lower claims costs from DM2 and hypertension complications.
Follow-up for chronic patients between visits at no in-person consultation cost. Reduction of avoidable readmissions.
The pharmacist receives structured patient data without having to call them. The pharmacy becomes an active care touchpoint.
ReflectEasy applies structured questions to detect drop-off signals before they happen — not post-hoc. No competitor captures that dataset.
Over 60, low digital literacy, history of abandonment. For this profile, the voice interface isn't a convenience — it's the only real access point.
Pre-abandonment signals captured through longitudinal conversation. Proprietary IP that no generalist model can replicate without that validation process.
The institutional client defines the protocols. Qonstio adapts to each programme's needs and portfolio — not the other way around.
"The patient who costs the system the most — and whom no current actor serves well — is the one who already abandoned one or more apps. For that profile, the voice interface completely changes the access equation."— Vanesa Bravo, Founder of ReflectEasy SL
Let's talk for 30 minutes. We'll run a live demo with a real call to the patient profile you're most interested in.
contacto@qonstio.com